Pathology At The Speed Of Thought

Course Faculty

Pediatric Pathology: Selected Topics for General Surgical Pathologists

Pediatric Pathology: Selected Topics for General Surgical Pathologists

May 15 - 17, 2019

Physicians Can Earn A Maximum Of 16 AMA PRA Category 1 Credits
Physicians Can Earn A Maximum Of 16 SAM Credit Hours
USCAP Member Price $1199
Register Now

Theonia K. Boyd

Theonia K. Boyd, M.D.
Boston Children’s Hospital, Harvard Medical School

Course Director

Dr. Boyd received her B.A. from Johns Hopkins University in 1984, and her M.D. from the University of Utah School of Medicine in 1988. She completed her Pathology residency at the University of North Carolina Hospitals in 1992. In 1995, following her Pediatric and Perinatal Pathology fellowship at Boston Children’s Hospital and Brigham and Women’s Hospital, she joined the faculty of Tufts University School of Medicine through Baystate Medical Center. She joined the faculty of Harvard Medical School in 2004, where she is currently an Associate Professor of Pathology, Director of Anatomic Pathology at Boston Children’s Hospital, and a Women’s and Perinatal Division pathologist in the Department of Pathology at Brigham and Women’s Hospital. She has published numerous peer reviewed manuscripts and many chapters on perinatal and placental pathology. She is co-author and co-editor of the textbook Diagnostic Gynecologic and Obstetric Pathology (Elsevier, 2nd edition, 2017) and co-author/co-editor of two books on placental pathology scheduled for publication in 2018. Dr. Boyd has a longstanding interest in placental pathology correlation with unexpected untoward fetal and neonatal outcomes. Dr. Boyd has given numerous placental and perinatal courses through Harvard Medical School Department of Continuing Medical Education, the Society for Pediatric Pathology and the United States and Canadian Academy of Pathology.

Jeffrey D. Goldsmith

Jeffrey D. Goldsmith, M.D.
Boston Children’s Hospital, Harvard Medical School

Course Director

Dr. Goldsmith received his B.S. degree from The University of Michigan in 1992 and his M.D. from Wayne State University School of Medicine in 1996. He then completed a residency in anatomic/clinical pathology at the University of Pennsylvania Medical Center in 2001 followed by a fellowship in gastrointestinal, liver, and surgical pathology in 2002. Dr. Goldsmith then became a staff pathologist at Beth Israel Deaconess Medical Center where he rose through the ranks and was most recently promoted to Associate Professor of Pathology at Harvard Medical School in 2015. He also served as the Director of the Surgical Pathology Laboratory from 2011-2016. In August of 2016, Dr. Goldsmith moved to Boston Children’s Hospital Department of Pathology where he currently serves as the Director of Gastrointestinal Pathology; he is also a consultant in gastrointestinal, bone and soft tissue pathology at Beth Israel Deaconess Medical Center. Dr. Goldsmith has served on many committees of the College of American Pathologists and has been active in the Rodger C. Haggitt Gastrointestinal Pathology Society; he served as the society’s president in 2016-2017. Dr. Goldsmith has published widely in the areas of gastrointestinal pathology and immunohistochemistry. He has lectured extensively and has participated in USCAP short courses and Harvard Medical School continuing medical education courses. In his personal life, he summers with his husband of 25 years in Provincetown MA, enjoys playing rudimentary classical piano pieces, and running through the dunes of Cape Cod.

Sanda Alexandrescu

Sanda Alexandrescu, M.D.
Boston Children’s Hospital, Harvard Medical School

Dr. Alexandrescu is a pediatric neuropathologist at Boston Children’s Hospital. She received her medical degree from The University of Medicine and Pharmacy “Victor Babes”, in Timisoara, Romania, in 2004 and then completed a residency in anatomic and clinical pathology at The University of Texas at Houston, followed by a pediatric pathology fellowship at Boston Children’s Hospital and a neuropathology fellowship at University of California at San Francisco. She is particularly interested in pediatric gliomas and molecular applications in the diagnosis of brain tumors (tissue triage, biobanking, test selection, process improvement). Dr. Alexandrescu is the neuropathologist for several pediatric glioma trials at Dana Farber Cancer Institute. On clinical service, she signs out all aspects of pediatric neuropathology (brain autopsy, sudden unexpected death in pediatrics through Robert’s Program, neoplastic and non-neoplastic specimens, epilepsy cases, nerve and muscle pathology, as well as ophthalmic pathology). She is a consultant neuropathologist on the molecular consult adult brain tumor service at The Brigham and Women’s Hospital, and is also credentialed at Beth Israel Deaconess Medical Center. When the schedule allows, Dr. Alexandrescu enjoys collaborating with several groups affiliated with Harvard Medical School, which focus on vascular anomalies and brain development in transgenic mice. Dr. Alexandrescu has had many presentations at national meetings and serves as the Chair of the Education Committee for the Society of Pediatric Pathology. In her spare time, she likes cooking and baking, gardening, running and involving her family in all these activities.

Alyaa Al-Ibraheemi

Alyaa Al-Ibraheemi, M.D.
Boston Children’s Hospital, Harvard Medical School

Dr. Al-Ibraheemi received her M.D. degree from The University of Baghdad Faculty of Medicine. After completing her training in Anatomical and Clinical pathology at the University of Texas at Houston, she joined Boston Children’s Hospital for a Pediatric Pathology fellowship program, and pursued further sub-specialization in Bone and Soft Tissue Pathology at the Mayo Clinic under the mentorship of Dr. Andrew Folpe. She joined the faculty of Harvard Medical School in 2016. She is currently a staff pathologist at Boston Children’s Hospital, where she provides clinical care, and teaching to medical students, residents and fellows. Her clinical interest and expertise revolve around the practice of pediatric mesenchymal tumors. Dr. Al-Ibraheemi has presented at several meetings, including an Interactive microscopy course at the 2018 annual meeting of the United States and Canadian Academy of Pathology. Her research interests encompass the study of genomic landscapes of pediatric solid tumors including malignant nerve sheath tumors, liver tumors and vascular tumors/anomalies. She serves as an ad hoc reviewer for many journals. Dr. Al-Ibraheemi is the lead pathologist for a central review for Neurofibromatosis (NF) Research Initiative GEM consortium (https://www.nfresearch-childrens.org/working-group-members/), a co-investigator on the pediatric arm of the Dana Farber Cancer Institute (DFCI) Profile study, and a co-investigator on the DFCI pediatric solid tumor banking protocol.

Mark D. Fleming

Mark D. Fleming, M.D., D.Phil
Boston Children’s Hospital, Harvard Medical School

Dr. Fleming is a hematological pathologist, the S. Burt Wolbach Professor of Professor of Pathology at Harvard Medical School and Chairman of Pathology at Boston Children's Hospital. He graduated from Princeton University with an A.B. in Molecular Biology, and was awarded a Marshall Scholarship to study organic chemistry at the university of Oxford and was awarded a D.Phil. Thereafter, he undertook an M.D. degree at the Harvard-MIT Health Sciences and Technology Division of Harvard Medical School and completed a residency in Anatomic Pathology and a fellowship in Hematopathology at Brigham and Women’s Hospital. He has practiced hematopathology for more than 20 years, the last 15 of which he has focused on pediatric hematopathology. His major research interest is in the area of iron and hematology. A second focus of his laboratory and his primary clinical interest is the pathology, pathophysiology and genetics of inherited bone marrow failure disorders and the pediatric myelodysplastic syndromes, including hereditary predispositions to these disorders. He has directed the Harvard Medical School second year hematology course for five years and has participated in numerous Harvard and American Society of Hematology CME courses and educational sessions on these topics.

Marian H. Harris

Marian H. Harris, M.D., Ph.D.
Boston Children’s Hospital, Harvard Medical School

Dr. Harris is the Director of the Laboratory for Molecular Pediatric Pathology (LaMPP) at Boston Children’s Hospital where she is a practicing hematopathologist and molecular pathologist. She received her M.D. and Ph.D. from the University of Pennsylvania, completed her residency in AP and fellowship in Hematopathology at Brigham and Women’s Hospital, and completed her fellowship in Molecular Genetic Pathology at Harvard Medical School. Dr. Harris’s clinical and translational research focuses on molecular diagnostics in the context of pediatric malignancy and hematologic disease. She is particularly interested in using molecular diagnostics to refine pathologic diagnoses, as well as to provide prognostic and therapeutic guidance in clinical care, and is a co-investigator on a number of multi-institutional clinical trials using molecular diagnostics for these purposes. She actively participates in teaching medical students, residents, and fellows at Boston Children’s Hospital, the Dana Farber Cancer Institute, and Harvard Medical School, is a speaker in the Harvard Medical School Department of Continuing Education hematopathology course, and was a co-organizer of the 2017 Society for Pediatric Pathology symposium “Personalized Medicine in the Practice of Pediatric Tumor Pathology.”